Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc ONCY


Primary Symbol: T.ONC

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune... see more

TSX:ONC - Post Discussion

View:
Post by gazzman on Aug 16, 2022 12:26pm

New here

Am looking to invest and am surprised by the targets of some analysts, yet the stock languishes well below these levels. Anuy thoughts on what gives?

Thanks

G
Comment by Buckhenry on Aug 16, 2022 12:46pm
I have owned a significant portion of this stock fir 3 years. have seen its ups and downs. more downs sorry to say. while there could be significant upside some one here are a little over zealous. until this stock gets over $10 a share it dont see major institution buyers getting in. it this stage it is like playing the roulette wheel at vegas.
Comment by westcoast1000 on Aug 16, 2022 1:07pm
Gazzman, It is a long long story. I recommend listening to the recent conference call and reading the corporate presentation. The targets you have seen barely reflect the potential that could be realized within 1-2 years. The low price reflects decades of waiting for a one product company to turn that product into a revenue strea, Back 5-6 years ago, the company had an entirely different focus, ...more  
Comment by askretka on Aug 17, 2022 8:01am
15$ US target by HC Wainwright has existed since FEB of 2021. Target has never been downgraded. They value Breast cancer treatments at 1.6 Billion US. $ 8.50 CDN target by Douglas Loe is probably most detailed. His 2030 earnings model predictsearnings of over 6$ per share which at 20x earnings gives us a potential future value of over 120$ a share. So why is stock price so low? Oncolytics has a ...more  
Comment by westcoast1000 on Aug 17, 2022 12:31pm
Askretka, I share your view about ONCY as an opportunity of a lifetime. But I have felt that for about 10 years and counting.
Comment by fox7mf on Aug 17, 2022 2:20pm
I also share the view that Onc is an opportunity of a lifetime...let's just make it this lifetime...better yet, in the next 60-90 days. Buyout time, Mr Parsons!!:)
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities